AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taku, K.
Right arrow Articles by Watanabe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taku, K.
Right arrow Articles by Watanabe, S.
Agricola
Right arrow Articles by Taku, K.
Right arrow Articles by Watanabe, S.
American Journal of Clinical Nutrition, Vol. 85, No. 4, 1148-1156, April 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials 1,2,3

Kyoko Taku, Keizo Umegaki, Yoko Sato, Yuko Taki, Kaori Endoh and Shaw Watanabe

1 From the Information Center (KT, KU, YS, YT, and KE) and the Nutritional Education Program (SW), National Institute of Health and Nutrition, Tokyo, Japan

Background: Clinical trials have reported the cholesterol-lowering effects of soy protein intake, but the components responsible are not known.

Objective: This meta-analysis was primarily conducted to evaluate the precise effects of soy isoflavones on lipid profiles. The effects of soy protein that contains enriched and depleted isoflavones were also examined.

Design: PUBMED was searched for English-language reports of randomized controlled trials published from 1990 to 2006 that described the effects of soy protein intake in humans. Eleven studies were selected for the meta-analysis.

Results: Soy isoflavones significantly decreased serum total cholesterol by 0.10 mmol/L (3.9 mg/dL or 1.77%; P = 0.02) and LDL cholesterol by 0.13 mmol/L (5.0 mg/dL or 3.58%; P < 0.0001); no significant changes in HDL cholesterol and triacylglycerol were found. Isoflavone-depleted soy protein significantly decreased LDL cholesterol by 0.10 mmol/L (3.9 mg/dL or 2.77%; P = 0.03). Soy protein that contained enriched isoflavones significantly decreased LDL cholesterol by 0.18 mmol/L (7.0 mg/dL or 4.98%; P < 0.0001) and significantly increased HDL cholesterol by 0.04 mmol/L (1.6 mg/dL or 3.00%; P = 0.05). The reductions in LDL cholesterol were larger in the hypercholesterolemic subcategory than in the normocholesterolemic subcategory, but no significant linear correlations were observed between reductions and the starting values. No significant linear correlations were found between reductions in LDL cholesterol and soy protein ingestion or isoflavone intakes.

Conclusions: Soy isoflavones significantly reduced serum total and LDL cholesterol but did not change HDL cholesterol and triacylglycerol. Soy protein that contained enriched or depleted isoflavones also significantly improved lipid profiles. Reductions in LDL cholesterol were larger in hypercholesterolemic than in normocholesterolemic subjects.

Key Words: Soy isoflavones • soy protein • lipid • total cholesterol • LDL cholesterol • HDL cholesterol • triacylglycerol • meta-analysis




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
M. V. Potenza and J. I. Mechanick
The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology
Nutr Clin Pract, October 1, 2009; 24(5): 560 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. A. Pipe, C. P. Gobert, S. E. Capes, G. A. Darlington, J. W. Lampe, and A. M. Duncan
Soy Protein Reduces Serum LDL Cholesterol and the LDL Cholesterol:HDL Cholesterol and Apolipoprotein B:Apolipoprotein A-I Ratios in Adults with Type 2 Diabetes
J. Nutr., September 1, 2009; 139(9): 1700 - 1706.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Messina, S. Watanabe, and K. D. R. Setchell
Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment
J. Nutr., April 1, 2009; 139(4): 796S - 802S.
[Abstract] [Full Text] [PDF]


Home page
Crop Sci.Home page
M. J. Morrison, E. R. Cober, M. F. Saleem, N. B. McLaughlin, J. Fregeau-Reid, B. L. Ma, W. Yan, and L. Woodrow
Changes in Isoflavone Concentration with 58 Years of Genetic Improvement of Short-Season Soybean Cultivars in Canada
Crop Sci., November 24, 2008; 48(6): 2201 - 2208.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Orgaard and L. Jensen
The Effects of Soy Isoflavones on Obesity
Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Thorp, P. R. Howe, T. A Mori, A. M Coates, J. D Buckley, J. Hodgson, J. Mansour, and B. J Meyer
Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 298 - 304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. M Geleijnse and P. C. Hollman
Flavonoids and cardiovascular health: which compounds, what mechanisms?
Am. J. Clinical Nutrition, July 1, 2008; 88(1): 12 - 13.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Hooper, P. A Kroon, E. B Rimm, J. S Cohn, I. Harvey, K. A Le Cornu, J. J Ryder, W. L Hall, and A. Cassidy
Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials
Am. J. Clinical Nutrition, July 1, 2008; 88(1): 38 - 50.
[Abstract] [Full Text] [PDF]


Home page
Menopause IntHome page
I. Rudkowska
Functional foods for cardiovascular disease in women
Menopause Int, June 1, 2008; 14(2): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
S. Vosough-Ghanbari, R. Rahimi, S. Kharabaf, S. Zeinali, A. Mohammadirad, S. Amini, N. Yasa, A. Salehnia, T. Toliat, S. Nikfar, et al.
Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial
Evid. Based Complement. Altern. Med., February 27, 2008; (2008) nen018v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y.-H. Chan, K.-K. Lau, K.-H. Yiu, S.-W. Li, H.-T. Chan, S. Tam, X.-O. Shu, C.-P. Lau, and H.-F. Tse
Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 938 - 945.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition